Hb Hammersmith [beta 42(CD1)Phe -> Ser]: Occurrence as a de novo mutation in black monozygotic twins with multiple congenital anomalies

Citation
Amm. Tuohy et al., Hb Hammersmith [beta 42(CD1)Phe -> Ser]: Occurrence as a de novo mutation in black monozygotic twins with multiple congenital anomalies, J PED H ONC, 20(6), 1998, pp. 563-566
Citations number
20
Categorie Soggetti
Pediatrics
Journal title
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
ISSN journal
10774114 → ACNP
Volume
20
Issue
6
Year of publication
1998
Pages
563 - 566
Database
ISI
SICI code
1077-4114(199811/12)20:6<563:HH[4-S>2.0.ZU;2-H
Abstract
Purpose: To present the occurrence of Hb Hammersmith as a de novo mutation in African-American twins with multiple congenital anomalies. Methods: Standard hematologic methods were used. The presence of an unstabl e Hb Variant was confirmed by brilliant cresyl blue staining and an isoprop anol stability test. Hb Hammersmith was confirmed by the sequencing of poly merase chain reaction-amplified beta-globin gene. Results: The presence of Hb Hammersmith was confirmed in female monozygotic twins of African-American origin with congenital Heinz body hemolytic anem ia and multiple congenital anomalies. The variant occurred as a de novo mut ation in the twins. Conclusion: This report describes the occurrence of Hb Hammersmith [B42(CD1 )Phe-->Ser] in African-American twins. As with the other reported cases, bo th twins were female. In addition to Heinz body hemolytic anemia, a low art erial O-2 saturation in the proposita was shown by pulse oximetry. Multiple congenital anomalies involving various systems were also found in both twi ns.